Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

NCT00236951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: iron sucrose injection USP
DRUG: stable erythropoietin therapy

Sponsor

American Regent, Inc.